| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.3 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |